2m 2m 2m 2m 2m 2m 2m
Silexion Therap (SLXN)
NASDAQ
$5.02+$0.16 (+3.27%)
Price as of Jun 03, 2026 7:58 PM EDT- N/AMarket Cap
- -96.50%1-Year Change
- BiotechnologyIndustry
Silexion Therap (SLXN)
$5.02+$0.16 (+3.27%)
SLXN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.86 | ||
Change | +$0.010 (+0.20%) | ||
Open | $4.87 | ||
High | $5.04 | ||
Low | $4.82 | ||
Previous Close | $4.99 | ||
Volume | 118,285 | ||
30-Day Average Volume | 1,695,688 | ||
1-Week Change | 16.24% | ||
1-Month Change | -16.60% | ||
1-Year Change | -96.50% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 4.2M | ||
Total Assets | $4.6M | ||
Market Cap | N/A | ||
Enterprise Value | N/A | ||
Period: QTR TTM FY | |||
Revenue | $32,000.00 | ||
Net Income | -$2.7M | ||
Free Cash Flow | -$3.6M | ||
EBIT | -$2.7M | ||
EBITDA | -$2.7M | ||
Net Working Capital | $5,000.00 | ||
EPS | $8.50 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | 71 | ||
P/E | 1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 05/29/2026 | ||
Earnings & Revenue